Skip to main content
TempraMed Technologies logo

TempraMed Technologies — Investor Relations & Filings

Ticker · VIVI ISIN · CA88024B1022 LEI · 529900AK4AXUNXYDWH07 CSE Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2026-01-23 Capital/Financing Update
Country CA Canada
Listing CSE VIVI

About TempraMed Technologies

https://tempramed.com

TempraMed Technologies Ltd. develops and markets innovative, temperature-controlled storage solutions for injectable and temperature-sensitive pharmaceuticals, focusing on "last mile" control management for patients and healthcare providers. The company utilizes patented, space-grade insulation technology in its FDA-registered medical devices. Key products include the VIVI Cap, a thermal carrying case for insulin pens and weight loss medications, and the VIVI Epi, a temperature shield for epinephrine auto-injectors (EpiPen). These compact, maintenance-free solutions require no batteries or charging, ensuring medications remain within optimal temperature ranges 24/7/365, thereby safeguarding drug efficacy and minimizing the risk of spoilage due to temperature extremes.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a 'Material Change Report' (Form 51-102F3) which serves as a formal regulatory filing. It primarily details a private placement financing (capital raise) and includes an update on the results of an Annual General Meeting (AGM). Since the document is a formal regulatory filing that encompasses both a capital raise and corporate governance updates, it is best classified as a Regulatory Filing (RNS) as it acts as a catch-all for these types of official material change disclosures.
2026-01-23 English
Report of exempt distribution (45-106F1).pdf
Capital/Financing Update Classification · 1% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a regulatory filing used in Canada to report the distribution of securities to investors under an exemption from the prospectus requirement. Since this document is a specific regulatory form detailing capital distribution and does not fit into the other specialized categories like 'SHA' (which is for general share issues) or 'CAP' (which is for general financing updates), it is best classified as a general regulatory filing.
2026-01-23 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued via Newsfile Corp. regarding a business development (independent validation of a ROI model). It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a regulatory filing of a specific form type. As it is a general corporate announcement regarding business operations and strategy, it falls under the fallback category of Regulatory Filings (RNS).
2026-01-14 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release covering two primary topics: a private placement financing (Capital/Financing Update) and the results of an Annual General Meeting (Declaration of Voting Results). Given the primary headline and the bulk of the content focus on the C$2.5 million private placement, 'CAP' is the most accurate classification for the financing activity. While it also contains voting results, the financing is the lead news item.
2026-01-12 English
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate press release announcing a business milestone (first commercial order and shipment to an Israeli distributor). It contains no financial results data, no governance or board changes, no share transactions, no dividend notice, no M&A, and no reference to publishing a formal report. It is not a regulatory-required filing like an Annual Report, Interim Report, or Earnings Release. It is best classified under the fallback category for general regulatory or corporate announcements that do not fit more specific categories: Regulatory Filings (RNS).
2026-01-06 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by TempraMed Technologies Ltd. regarding a commercial milestone (first commercial order and shipment in Israel). It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement (RPA) as it describes the business event itself rather than just announcing the availability of a report. As it is a general corporate announcement regarding business operations and market expansion, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2026-01-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.